CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fuso Pharmaceutical Industries Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fuso Pharmaceutical Industries Ltd
1-7-10, Dosho-machi, Chuo-ku
Phone: +81 662316887p:+81 662316887 OSAKA-SHI, OSK  541-0045  Japan Ticker: 45384538

Business Summary
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20233/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Representative Director MikioToda 80 2/1/1979 5/1/1969
Chief Director of Sales, Director HidekiOtani 58 6/1/2021 6/29/2017
Executive Officer, Manager of Tokyo 1st Office in Main Sales Office Unit KiyoshiTajima 6/29/2023 6/29/2023
11 additional Officers and Directors records available in full report.

Business Names
Business Name
4538
Fuso Pharmaceutical Industries, Ltd.

General Information
Number of Employees: 1,314 (As of 3/31/2023)
Outstanding Shares: 8,461,999 (As of 12/31/2023)
Shareholders: 5,049
Stock Exchange: TYO
Fax Number: +81 669692341


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024